Telik (TELK)
Add to Watchlists Create an AlertTELK Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -3.007 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -7.631M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 6.019M |
| Enterprise Value | 0.4022M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 1.245 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | |
| Return on Equity | -156.7% |
TELK News
- TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Submiss... May 20
- Telik Announces First Quarter 2013 Financial Results PR Newswire May 10
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Fin... May 10
- Telik: A Possible Investment, But Only After Much Consideration Apr 5
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Fin... Mar 15
- Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Fina... Mar 15
- TELIK INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financ... Mar 5
- TELIK INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Fi... Feb 22
- Is There Value In Telik? Jan 24
- 4 Healthcare Stock Stories for Wednesday Wellness Jan 23
TELK Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Telik is down 69.52% over the last year vs S&P 500 Total Return up 28.03%, Acura Pharmaceuticals down 18.06%, and Horizon Pharma down 37.11%.
TELK Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TELK related companies
Pro Ratings for TELK
Pro Report PDF for TELK
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TELK Pro Report PDF
Pro Strategies Featuring TELK
Did Telik make it into our Pro Portfolio Strategies?
TELK Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Other TELK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TELK | 1.32 | +0.00 | +0.00% | 6.019M |
